TP53 and neoplasm: Furthermore, tumours with mutant TP53—a potent tumour-suppressor gene that is thought to guard against WGD+ and aneuploid cells continuing through successive cell cycles and proliferating—were significantly associated with WGD+ (1.8-fold increase in frequency), as well as chromothripsis (1.54-fold increase) [55,81].